BUSDMBoston University School of Dental Medicine (Boston, MA)
References in periodicals archive ?
BUSDM was selected because of its proven track record in creating companies to develop new technologies in dentistry.
If further developed and commercialized by BUSDM, H2 Antagonist Technology could provide significant oral health benefits to the millions of people around the world who suffer from gingivitis and periodontitis.